文献速递瓣膜外科

Ross翻转术挽救自体移植物的早中期结果:单瓣膜病不必变为双瓣膜病

Early and mid-term results of autograft rescue by Ross reversal: A one-valve disease need not become a two-valve disease.
PubMed 文献 · J Thorac Cardiovasc Surg · 2017-10-31

该研究回顾了2006至2017年间30例因自体移植主动脉瓣功能障碍而接受Ross翻转术(将失败的自体移植物放回肺动脉位置)的患者,随访4.1±3.5年,无手术死亡,随访期间无再手术,24例肺动脉瓣功能可接受,6例有临床耐受良好的中重度肺动脉瓣反流。

要点

  • Ross翻转术可将失败的自体移植主动脉瓣放回肺动脉位置,避免丢失两个自身瓣膜。
  • 30例Ross翻转术患者无手术死亡,随访期间无再手术。
  • 24例肺动脉瓣功能可接受,6例有临床耐受良好的中重度肺动脉瓣反流。

核心结论

  • Ross翻转术可在低并发症率下完成,并获得可接受的肺动脉瓣功能,降低自体移植主动脉瓣失败时患者失去两个自身瓣膜的风险。

研究设计与样本

  • 回顾性 review,2006年至2017年共39例因自体移植瓣功能障碍再手术,其中30例成功行Ross翻转术并纳入分析。

主要发现

  • 30例Ross翻转术患者无手术死亡,1例因出血再手术,1例因使用心内球囊阻断钳导致腹主动脉损伤。
  • 术后中位住院时间为7.2天(范围4-41天),随访期间无患者需要再手术。
  • 随访时24例肺动脉瓣功能可接受,6例有临床耐受良好的中重度肺动脉瓣反流。
  • 从原Ross手术到Ross翻转术的中位间隔为12年(范围5-19年)。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVES: Risk of reoperation and loss of a second native valve are major drawbacks of the Ross operation. Rather than discarding the failed autograft, it can be placed back into the native pulmonary position by "Ross reversal." We review our early and mid-term results with this operation. METHODS: From 2006 to 2017, 39 patients underwent reoperation for autograft dysfunction. The autograft was successfully rescued in 35 patients: by Ross reversal in 30, David procedure in 4, and autograft repair in 1. Medical records were reviewed for patient characteristics (mean age was 46 ± 13 years, range 18-67 years, and 23 were male), previous operations, indications for reoperation, hospital outcomes, and echocardiographic findings for the 30 patients undergoing successful Ross reversal. Follow-up was 4.1 ± 3.5 years (range 7 months-11 years). RESULTS: Median interval between the original Ross procedure and Ross reversal was 12 years (range 5-19 years). Eight patients also had absolute indications for replacement of the pulmonary allograft. There was no operative mortality. One patient required reoperation for bleeding. Another had an abdominal aorta injury from use of an endoballoon clamp. There was no other major postoperative morbidity, and median postoperative hospital stay was 7.2 days (range 4-41 days). No patient required reoperation during follow-up. Twenty-four patients had acceptable pulmonary valve function, and 6 had clinically well-tolerated moderate or severe pulmonary regurgitation. CONCLUSIONS: Ross reversal can be performed with low morbidity and acceptable pulmonary valve function, reducing patient risk of losing 2 native valves when the autograft fails in the aortic position.

来源:J Thorac Cardiovasc Surg,查看原文。版权归原作者所有。

引用

  1. Hussain ST, Majdalany DS, Dunn A, et al. Early and mid-term results of autograft rescue by Ross reversal: A one-valve disease need not become a two-valve disease. J Thorac Cardiovasc Surg. 2017. PMID: 29415381. doi:10.1016/j.jtcvs.2017.09.134

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。